ATM and anemia: Although, at first glance, targeting a tumor suppressor gene could not enhance cancer cell killing, recently a CRISPR screen revealed key FANCONI anemia/BRCA pathway genes as strong synthetic lethality with ATM in the presence of ATM inhibitors (ATMi).